info@shantani.com | Tel: +91-20-64103918, +91-20-64009991



Small Molecule Target Deconvolution using Advanced Chemical Proteomics.



CSOs at Biotech Enterprises }
Academics & P.I.s
Technology Scouts at Big Pharma
Phenotypic / Cell-based Leads (PDD)
What is the target for the molecule?

How does the molecule work?

Proceed to Phase 1 trials?

Is repurposing possible?
Target-based Lead Compounds (TDD)
Drug Repurposing & Repositioning
 
Shantani's Chemical Proteomics Technology
(Click for more.)
 

Fewer & Rightful Targets

Mechanism of Action

New (Secondary) Targets

Off-target Information
Rational Lead Optimization
Tox Profiling & Candidate Selection Strategies
Scientific Rationale for New Indications

Sign up for Shantani's services to save 50% - 70% in costs & cycle time!


We Enable Faster, Cost-Effective Drug Discovery & Development

Shantani is a privately-held biotechnology company based in Pune, India. Our chemical-proteomics technology identifies & validates drug targets; thus de-risking molecules and supporting crucial GO / NO-GO decisions throughout the drug discovery process.

Our proprietary work-flow provides comprehensive information about both the target and the action mechanism of bioactive molecules, via a unique combination of chemical biology, biophysics and cell & molecular biology methods.

By identifying fewer - yet rightful - targets and avoiding the validation of false positives, we help you save time and money during the drug discovery process.

We have successfully identified cytoplasmic (ie. kinases), membrane (ie. GPCRs) and nuclear targets.

News, Updates

  • Shantani's CEO featured in Biospectrum

    BioSpectrum's CSO series on scientists who are driving innovation in the life sciences.

    more »

  • Shantani receives its second DBT-SBIRI Grant

    Small Business Innovation Research Initiative Grant from the Dept of Biotechnology, GoI.

    more »